Authors:
Van der Looij, M
Papp, J
Sztan, M
Pulay, T
Elfadil, I
Besznyak, I
Toth, J
Devilee, P
Olah, E
Citation: M. Van Der Looij et al., Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors, INT J ONCOL, 18(4), 2001, pp. 775-780
Authors:
Benko, I
Kovacs, P
Szegedi, I
Megyeri, A
Kiss, A
Balogh, E
Olah, E
Kappelmayer, J
Kiss, C
Citation: I. Benko et al., Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia, N-S ARCH PH, 363(5), 2001, pp. 499-508
Authors:
Forster-Horvath, C
Bocsi, J
Raso, E
Orban, TI
Olah, E
Timar, J
Ladanyi, A
Citation: C. Forster-horvath et al., Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes, EUR J IMMUN, 31(2), 2001, pp. 600-608
Citation: Ti. Orban et E. Olah, Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines, BIOC BIOP R, 280(1), 2001, pp. 32-38
Authors:
van der Looij, M
Cleton-Jansen, AM
van Eijk, R
Morreau, H
van Vliet, M
Kuipers-Dijkshoorn, N
Olah, E
Cornelisse, CJ
Devilee, P
Citation: M. Van Der Looij et al., A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1, GENE CHROM, 27(3), 2000, pp. 295-302
Authors:
Beck, Z
Kiss, A
Toth, FD
Szabo, J
Bacsi, A
Balogh, E
Borbely, A
Telek, B
Kovacs, E
Olah, E
Rak, K
Citation: Z. Beck et al., Alterations of P53 and RB genes and the evolution of the accelerated phaseof chronic myeloid leukemia, LEUK LYMPH, 38(5-6), 2000, pp. 587-597
Citation: Ti. Orban et al., Sequence alterations can mask each other's presence during screening with SSCP or heteroduplex analysis: BRCA genes as examples, BIOTECHNIQU, 29(1), 2000, pp. 94
Authors:
Van der Looij, M
Szabo, C
Besznyak, I
Liszka, G
Csokay, B
Pulay, T
Toth, J
Devilee, P
King, MC
Olah, E
Citation: M. Van Der Looij et al., Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary, INT J CANC, 86(5), 2000, pp. 737-740
Authors:
Mazoyer, S
Leary, J
Kirk, J
Fleischmann, E
Wagner, T
Claes, K
Messiaen, L
Foulkes, W
Desrochers, M
Simard, J
Phelan, CM
Kwan, E
Narod, SA
Vahteristo, P
Nevanlinna, H
Durando, X
Bignon, YJ
Peyrat, JP
Bonnardel, C
Sinilnikova, OM
Puget, N
Lenoir, GM
Mazoyer, S
Audoynaud, C
Goldgar, D
Maugard, C
Caux, V
Gad, S
Stoppa-Lyonnet, D
Nogues, C
Lidereau, R
Machavoine, C
Bressac-de Paillerets, B
Kuschel, B
Betz, B
Niederacher, D
Beckmann, MW
Hamann, U
Gayther, SA
Ponder, BAP
Robinson, M
Taylor, GR
Bishop, T
Catteau, A
Solomon, E
Cohen, B
Steel, M
Collins, N
Stratton, M
van der Looij, M
Olah, E
Miller, NJ
Barton, DE
Sverdlov, RS
Friedman, E
Radice, P
Montagna, M
Sensi, E
Caligo, M
van Eijk, R
Devilee, P
van der Luijt, R
Heimdal, K
Moller, P
Borg, A
Diez, O
Cortes, J
Domenech, M
Baiget, M
Osorio, A
Benitez, J
Borg, A
Maillet, P
Sappino, AP
Ozdag, H
Ozcelik, T
Ozturk, M
Rohlfs, EM
Boyd, J
McDermott, D
Offit, K
Unger, M
Nathanson, K
Weber, BL
Sellers, TA
Hampton, E
Couch, FJ
Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Authors:
Laake, K
Launonen, V
Niederacher, D
Gudlaugsdottir, S
Seitz, S
Rio, P
Champeme, MH
Bieche, I
Birnbaum, D
White, G
Sztan, M
Sever, N
Plummer, S
Osorio, A
Broeks, A
Huusko, P
Spurr, N
Borg, A
Cleton-Jansen, AM
van't Veer, L
Benitez, J
Casey, G
Peterlin, B
Olah, E
Varley, J
Bignon, YJ
Scherneck, S
Sigurdardottir, V
Lidereau, R
Eyfjord, J
Beckmann, MW
Winqvist, R
Skovlund, E
Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221
Authors:
Papp, J
Raicevic, L
Milasin, J
Dimitrijevic, B
Radulovic, S
Olah, E
Citation: J. Papp et al., Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families, ONCOL REP, 6(6), 1999, pp. 1435-1438
Authors:
Morrison, PJ
Steel, CM
Vasen, HFA
Eccles, D
Evans, DGR
Moller, P
Hodgson, S
Stoppa-Lyonnet, D
Chang-Claude, J
Caligo, M
Olah, E
Haites, NE
Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165
Authors:
Csokay, B
Udvarhelyi, N
Sulyok, Z
Besznyak, I
Ramus, S
Ponder, B
Olah, E
Citation: B. Csokay et al., High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history, CANCER RES, 59(5), 1999, pp. 995-998
Authors:
Launonen, V
Laake, K
Huusko, P
Niederacher, D
Beckmann, MW
Barkardottir, RB
Geirsdottir, EK
Gudmundsson, J
Rio, P
Bignon, YJ
Seitz, S
Scherneck, S
Bieche, I
Champeme, MH
Birnbaum, D
White, G
Varley, J
Sztan, M
Olah, E
Osorio, A
Benitez, J
Spurr, N
Velikonja, N
Peterlin, B
Borg, A
Cleton-Jansen, AM
Devilee, P
Bloigu, R
Lidereau, R
Borresen-Dale, AL
Winqvist, R
Citation: V. Launonen et al., European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables, BR J CANC, 80(5-6), 1999, pp. 879-882
Citation: B. Ribar et al., Deletion of the sep1(+) forkhead transcription factor homologue is not lethal but causes hyphal growth in Schizosaccharomyces pombe, BIOC BIOP R, 263(2), 1999, pp. 465-474